S
Stephen M. Shaw
Publications - 1
Citations - 243
Stephen M. Shaw is an academic researcher. The author has contributed to research in topics: Chemotherapy & Pembrolizumab. The author has an hindex of 1, co-authored 1 publications receiving 93 citations.
Papers
More filters
Journal ArticleDOI
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Bruno Bockorny,Bruno Bockorny,Valerya Semenisty,Teresa Macarulla,Erkut Borazanci,Brian M. Wolpin,Salomon M. Stemmer,Salomon M. Stemmer,Talia Golan,Talia Golan,Ravit Geva,Ravit Geva,Mitesh J. Borad,Katrina S. Pedersen,Joon Oh Park,Robert A. Ramirez,David Gutierrez Abad,Jaime Feliu,Andrés Muñoz,Mariano Ponz-Sarvise,Amnon Peled,Tzipora M. Lustig,Osnat Bohana-Kashtan,Stephen M. Shaw,Ella Sorani,Marya F. Chaney,Shaul Kadosh,Abi Vainstein Haras,Daniel D. Von Hoff,Manuel Hidalgo,Manuel Hidalgo +30 more
TL;DR: Results from the phase IIa COMBAT trial combining CXCR4 and PD-1 inhibition in patients with metastatic cancer show encouraging clinical responses in association with enhanced antitumor immune activation.